Busting Real-World Data and AI Myths

Run Time

15 minutes

Artificial intelligence is transforming how life sciences organizations unlock the full value of real-world data—but success depends on more than AI alone. In this episode of Real-World Data After Dark, Daniel Chancellor is joined by Kris Kaneta, Chief Product & Innovation Officer at Norstella, and Ted Search, Chief Real-World Data & Analytics Officer at Norstella, to separate fact from fiction around AI in healthcare. Together, they explore how AI is accelerating clinical research, uncovering insights from previously inaccessible unstructured data, improving clinical trial planning and patient recruitment, and enabling faster, more informed commercial decisions—all while emphasizing the critical role of human expertise in validating AI-generated insights and turning them into real-world impact.

Frequently asked questions

How is AI changing the way life sciences organizations use real-world data?
AI is making it possible to analyze massive volumes of structured and unstructured real-world data faster than ever before, helping organizations uncover deeper patient insights, improve commercial strategies, and accelerate evidence generation.
Can AI replace clinical and data experts?
No. While AI can rapidly identify patterns and surface valuable insights, human expertise remains essential to validate findings, apply clinical context, and ensure decisions are accurate, actionable, and compliant.
How does AI improve clinical trial planning and patient recruitment?
AI helps identify eligible patient populations, optimize investigator and site selection, predict trial timelines, and uncover recruitment opportunities—making clinical trials more efficient and increasing the likelihood of successful enrollment.
Why is unstructured real-world data so valuable?
Unstructured data, such as physician notes and electronic medical records, contains rich clinical information that has traditionally been difficult to analyze. AI can now extract insights like biomarkers, disease progression, tumor stage, and physician rationale at scale, enabling better research, commercial decisions, and patient care.
Daniel-Chancellor
Dan Chancellor
VP, Thought Leadership, Norstella
madeline-naylor-headshot
Dr. Madeline Naylor, DHSc, MMS, CCRP
Chief Clinician, Norstella
lance-wolkenbrod-headshot
Lance Wolkenbrod
Senior Principal, Real-World Data Solutions, Norstella

Norstella Brands